Download PDF
Horm Metab Res 2020; 52(04): 251
DOI: 10.1055/a-1089-7739
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Concerning the Article by Arezoo Maleki-Hajiagha et al. entitled: Serum Prostate-Specific Antigen Level in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Michał Kunicki
1   Department of Gynecological Endocrinology, Medical University of Warsaw, Warsaw, Poland
2   INVICTA Fertility and Reproductive Center, Warsaw, Poland
,
Ewa Rudnicka
1   Department of Gynecological Endocrinology, Medical University of Warsaw, Warsaw, Poland
,
Roman Smolarczyk
1   Department of Gynecological Endocrinology, Medical University of Warsaw, Warsaw, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
08 April 2020 (online)

Also available at
    Permissions and Reprints

Letter to:

Serum Prostate-Specific Antigen Level in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-analysisHorm Metab Res 2019; 51(04): 230-242
DOI: 10.1055/a-0863-5779

Dear Editor,

We carefully read with a great interest the study of Arezoo Maleki-Hajiagha et al. entitled: Serum Prostate-Specific Antigen Level in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis [1]. We thank the authors for their hard work and also citing our latest work in this field-covering the largest study population ( Rudnicka et al. 2016) [2]. However, we think that the title of that meta-analysis is not appropriate and the conclusions are not adequate.

 

  • References

  • 1 Maleki-Hajiagha A, Razavi M, Rezaeinejad M. et al. Serum prostate-specific antigen level in women with polycystic ovary syndrome: A systematic review and meta-analysis. Horm Metab Res 2019; 51: 230-242
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Rudnicka E, Radowicki S, Suchta K. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight. Gynecol Endocrinol 2016; 32: 931-935
    CrossrefPubMedGoogle Scholar